Update - BioMarin to hire 50 people at Shanbally
US FDA clears BioMarin to make $380,000-a year Vimizim in Ireland
The US FDA has cleared BioMarin Pharmaceutical Inc. to make the enzyme replacement drug Vimizim (elosulfase alfa) at its plant in Cork, Ireland.